2kuh: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
==Halothane binds to druggable sites in calcium-calmodulin: Solution structure of halothane-CaM C-terminal domain== | ==Halothane binds to druggable sites in calcium-calmodulin: Solution structure of halothane-CaM C-terminal domain== | ||
<StructureSection load='2kuh' size='340' side='right'caption='[[2kuh | <StructureSection load='2kuh' size='340' side='right'caption='[[2kuh]]' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[2kuh]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/ | <table><tr><td colspan='2'>[[2kuh]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2KUH OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2KUH FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> | ||
<tr id=' | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=HLT:2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE'>HLT</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2kuh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2kuh OCA], [https://pdbe.org/2kuh PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2kuh RCSB], [https://www.ebi.ac.uk/pdbsum/2kuh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2kuh ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2kuh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2kuh OCA], [https://pdbe.org/2kuh PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2kuh RCSB], [https://www.ebi.ac.uk/pdbsum/2kuh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2kuh ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | |||
[https://www.uniprot.org/uniprot/CALM1_HUMAN CALM1_HUMAN] The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM1 are the cause of CPVT4. The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM1 are the cause of LQT14. | |||
== Function == | |||
[https://www.uniprot.org/uniprot/CALM1_HUMAN CALM1_HUMAN] Calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding. Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases and phosphatases. Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis (PubMed:16760425). Mediates calcium-dependent inactivation of CACNA1C (PubMed:26969752). Positively regulates calcium-activated potassium channel activity of KCNN2 (PubMed:27165696).<ref>PMID:16760425</ref> <ref>PMID:23893133</ref> <ref>PMID:26969752</ref> <ref>PMID:27165696</ref> | |||
== Evolutionary Conservation == | == Evolutionary Conservation == | ||
[[Image:Consurf_key_small.gif|200px|right]] | [[Image:Consurf_key_small.gif|200px|right]] | ||
Line 22: | Line 25: | ||
==See Also== | ==See Also== | ||
*[[Calmodulin 3D structures|Calmodulin 3D structures]] | *[[Calmodulin 3D structures|Calmodulin 3D structures]] | ||
== References == | |||
<references/> | |||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Homo sapiens]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Hock | [[Category: Hock TJ]] | ||
[[Category: Jones | [[Category: Jones KA]] | ||
[[Category: Juranic | [[Category: Juranic N]] | ||
[[Category: Macura | [[Category: Macura S]] | ||
[[Category: Penheiter | [[Category: Penheiter AR]] | ||
[[Category: Simeonov | [[Category: Simeonov MV]] | ||
[[Category: Streiff | [[Category: Streiff JH]] | ||
Latest revision as of 09:48, 1 May 2024
Halothane binds to druggable sites in calcium-calmodulin: Solution structure of halothane-CaM C-terminal domainHalothane binds to druggable sites in calcium-calmodulin: Solution structure of halothane-CaM C-terminal domain
Structural highlights
DiseaseCALM1_HUMAN The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM1 are the cause of CPVT4. The disease is caused by mutations affecting the gene represented in this entry. Mutations in CALM1 are the cause of LQT14. FunctionCALM1_HUMAN Calmodulin mediates the control of a large number of enzymes, ion channels, aquaporins and other proteins through calcium-binding. Among the enzymes to be stimulated by the calmodulin-calcium complex are a number of protein kinases and phosphatases. Together with CCP110 and centrin, is involved in a genetic pathway that regulates the centrosome cycle and progression through cytokinesis (PubMed:16760425). Mediates calcium-dependent inactivation of CACNA1C (PubMed:26969752). Positively regulates calcium-activated potassium channel activity of KCNN2 (PubMed:27165696).[1] [2] [3] [4] Evolutionary Conservation![]() Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. See AlsoReferences
|
|